Kura Oncology, Inc. (KURA) Institutional Ownership

Ownership Summary

Kura Oncology, Inc. (NASDAQ:KURA) has 208 institutional investors with active 13F positions as of December 2025.

• These investors collectively held 97.1% of Kura Oncology's outstanding shares in December 2025, up from 96.8% in September 2025.
• Their total shares held in KURA increased 4.79% quarter over quarter, and separately, investors owning Kura Oncology increased 13.66% from a year ago.
• During the quarter, 128 of these 208 funds increased positions in KURA, 53 reduced exposure, and 27 held steady.
• The aggregate institutional position in Kura Oncology amounted to 85.09Mn shares as of December 2025, up by 3.89Mn shares quarter on quarter, and up 2.75Mn shares year over year.
• BlackRock, Inc. leads ownership in KURA with 9.64Mn shares as of December 31, 2025, equal to 11.0% of outstanding shares.
• The most significant purchases of KURA for the quarter ending December 2025 came from VANGUARD CAPITAL MANAGEMENT LLC (3.79Mn), Deep Track Capital, LP (2.64Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (1.23Mn), BlackRock, Inc. (626.74K), VANGUARD FIDUCIARY TRUST CO (554.98K).
• Top sellers of KURA stock for the quarter ending December 2025 included Goldman Sachs Group Inc (2.24Mn), JACOBS LEVY EQUITY MANAGEMENT, INC (1.42Mn), ARMISTICE CAPITAL, LLC (1.2Mn), AQR CAPITAL MANAGEMENT LLC (937.73K), Assenagon Asset Management S.A. (805.3K).
• Per Business Quant data, the top 10 holders of Kura Oncology for the quarter ending December 2025 are BlackRock, Inc. (9.64Mn), SUVRETTA CAPITAL MANAGEMENT, LLC (8.58Mn), BVF INC/IL (8.45Mn), State Street Corp (4.51Mn), VANGUARD CAPITAL MANAGEMENT LLC (3.79Mn), ARMISTICE CAPITAL, LLC (3.74Mn), Deep Track Capital, LP (2.64Mn), AQR CAPITAL MANAGEMENT LLC (2.12Mn), GEODE CAPITAL MANAGEMENT, LLC (2.03Mn), Qube Research & Technologies Ltd (1.64Mn).